ZG16B Activators
ZG16B Activators encompass a spectrum of chemical compounds that upregulate the functional activity of ZG16B by interfacing with various intracellular signaling pathways. Forskolin, Isoproterenol, IBMX, Dibutyryl-cAMP, and Rolipram increase intracellular cAMP levels, subsequently activating PKA, which may phosphorylate ZG16B, thus enhancing its activity. Sildenafil and IBMX also raise cGMP concentrations, leading to PKG activation, which could similarly phosphorylate and activate ZG16B. Phorbol 12-myristate 13-acetate serves as a PKC activator, potentially phosphorylating ZG16B. Epigallocatechin gallate acts as a kinase inhibitor, and by inhibiting kinases that negatively regulate ZG16B, it could indirectly promote ZG16B activity.
Compounds such as Ionomycin, A23187, and Capsaicin increase intracellular calcium levels, engaging calcium-dependent signaling pathways that could influence ZG16B activity, provided ZG16B is part of or regulated by these calcium-mediated processes. The activity of ZG16B is further modulated by LY294002, a PI3K inhibitor, which may enhance ZG16B activity by reducing PI3K/AKT pathway-mediated inhibition, assuming ZG16B is negatively regulated by this pathway.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, thereby increasing levels of cAMP in the cell. Elevated cAMP activates PKA, which can phosphorylate and activate various proteins. If ZG16B activity is cAMP-dependent, Forskolin would enhance its function by this secondary messenger pathway. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). PKC phosphorylates target proteins, potentially including ZG16B if it is a substrate, thereby enhancing ZG16B’s activity within its specific signaling context. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent signaling pathways. If ZG16B function is regulated by calcium signaling, ionomycin would enhance ZG16B activity through this mechanism. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that activates adenylyl cyclase via G-protein coupled receptor signaling, increasing cAMP levels and subsequently activating PKA. If ZG16B is a PKA substrate, isoproterenol would enhance its activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit certain protein kinases. If ZG16B is regulated by a kinase that is inhibited by EGCG, then EGCG could enhance ZG16B activity by reducing negative regulatory phosphorylation events. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, leading to increased levels of cAMP and/or cGMP by preventing their degradation. If ZG16B activity is regulated by cAMP or cGMP, IBMX would enhance its function via these secondary messengers. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels. This increase can activate downstream calcium-dependent proteins. If ZG16B activity is influenced by calcium signaling, A23187 would enhance its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that affects the AKT signaling pathway. If ZG16B is negatively regulated by PI3K/AKT signaling, LY294002 could enhance ZG16B activity by alleviating this inhibition. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable analog of cAMP that activates PKA. If ZG16B is a PKA substrate, this compound would enhance its activity by mimicking the effects of cAMP. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective PDE4 inhibitor, leading to increased cAMP levels in cells. Enhanced cAMP levels activate PKA, which could enhance ZG16B function if it is cAMP-PKA pathway dependent. | ||||||